Home › Funds › SMITH CHAS P & ASSOCIATES PA CPAS › NVO
SMITH CHAS P & ASSOCIATES PA CPAS position in NVO
NOVO-NORDISK A S · Health Care
SMITH CHAS P & ASSOCIATES PA CPAS reported holding 950,151 shares of NVO (NOVO-NORDISK A S) in its Q2 2026 13F filing — a position valued at US$45.6M, representing 2.31% of its reported portfolio and ranking #18 among its reported holdings. SMITH CHAS P & ASSOCIATES PA CPAS has disclosed NVO holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SMITH CHAS P & ASSOCIATES PA CPAS's NVO position evolved
SMITH CHAS P & ASSOCIATES PA CPAS first disclosed a stake in NVO in Q1 2025 at 81,053 shares (US$5.6M). The position peaked in Q2 2026 at 950,151 shares, worth US$45.6M. Across 6 filings, SMITH CHAS P & ASSOCIATES PA CPAS increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 950,151 shares valued at US$45.6M — an increase of 148,565 shares quarter over quarter.. Notable position changes include a 144% increase in Q2 2025 (shares fell 20% over the following quarter), a 105% increase in Q3 2025 (shares fell 8% over the following quarter), a 41% increase in Q4 2025 (shares fell 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 81.05K | $5.63M | New |
| Q2 2025 | 197.47K | $13.63M | Add |
| Q3 2025 | 405.43K | $22.50M | Add |
| Q4 2025 | 570.71K | $29.04M | Add |
| Q1 2026 | 801.59K | $29.46M | Add |
| Q2 2026 | 950.15K | $45.55M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVO and 13F data
NVO (NOVO-NORDISK A S) is a Health Care company. 15 other funds we track also report a position in NVO — the largest reported positions include LOOMIS SAYLES & CO L P (US$891.4M), FOLKETRYGDFONDET (US$456.5M), EVERETT HARRIS & CO /CA/ (US$310.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVO
- LOOMIS SAYLES & CO L P 18.59M sh · $891.41M · Q2 2026
- FOLKETRYGDFONDET 9.52M sh · $456.50M · Q2 2026
- EVERETT HARRIS & CO /CA/ 6.48M sh · $310.44M · Q2 2026
More on SMITH CHAS P & ASSOCIATES PA CPAS
FAQ
How long has SMITH CHAS P & ASSOCIATES PA CPAS held NVO?
SMITH CHAS P & ASSOCIATES PA CPAS has disclosed NVO holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is SMITH CHAS P & ASSOCIATES PA CPAS's current position in NVO?
As of Q2 2026, SMITH CHAS P & ASSOCIATES PA CPAS holds 950.15K shares of NVO (NOVO-NORDISK A S), valued at $45.55M, representing 2.31% of its reported portfolio and ranking #18.
Has SMITH CHAS P & ASSOCIATES PA CPAS been buying or selling NVO?
In the latest 13F filing (Q2 2026), SMITH CHAS P & ASSOCIATES PA CPAS increased its position in NVO. The position peaked in Q2 2026 at 950.15K shares.
Which other funds hold NVO?
Other major institutional holders of NVO include LOOMIS SAYLES & CO L P, FOLKETRYGDFONDET, EVERETT HARRIS & CO /CA/, among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.